[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].

Article

[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].

Przeglad lekarski - 1 Jan 1992

Idzior-Waluś B

Abstract excerpt

30 male patients, aged 18-70 years, with primary hyperlipoproteinemia (HLP) IIa (20 persons) and IIb (10 persons), with total serum cholesterol concentration above 6.5 mmol/l and triglyceride concentration below 3.9 mmol/l were treated with lovastatin for 12 weeks, after 4 weeks of wash-out and 4...

Topics

Adolescent
Adult
Aged
Humans
Hyperlipidemias
Hyperlipoproteinemias
Lipids
Lovastatin
Male
Middle Aged
Phenotype

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.